Document is current

Article History

Received: 9 September 2024

Accepted: 8 January 2025

First Online: 22 January 2025

Declarations

:

: The study complied with the Declaration of Helsinki and was approved by the French ethics committee ‘Ouest-VI’ (CPP 1083-HPS2). All patients provided written informed consent. Clinical trial registration: NCT03592108 at ClinicalTrials.gov.

: Not applicable.

: Arnaud Prigent is a consultant for Resmed and reports personal fees from Elia Medical, AIR LIQUIDE SANTE, payment for presentations from RESMED Bastide, SOS oxygene, GSK and Isis medical, outside the submitted work. non-financial support from AIR LIQUIDE SANTE, ASTEN SANTE, SOS O2, Elia Medical, outside the submitted work.Joëlle Texereau, MD, PhD, is an employee of Air Liquide Healthcare.Sébastien Bailly, Dr Renaud Gervais, Anne-Laure Serandour, Dr Régis Luraine declare no conflict of interest.Jean Louis Pepin is supported by the French National Research Agency in the framework of the Investissements d’Avenir program [Grant ANR-15-IDEX-02] and the e-Health and Integrated Care chair of excellence from the Grenoble Alpes University Foundation and Sleep-AI chair in Artificial Intelligence MIAI cluster (ANR-19- P3IA-0003). He reports lecture fees or conference traveling grants from ResMed, Philips, Jazz Pharmaceuticals, Agiradom, Bastide, and Bioprojet.